Matches in SemOpenAlex for { <https://semopenalex.org/work/W2460765542> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2460765542 endingPage "5; discussion 136" @default.
- W2460765542 startingPage "131" @default.
- W2460765542 abstract "About 10 years ago, the first reports about the successful treatment of autoimmune thrombocytopenia with high-dose intravenously administered immunoglobulins (ivIg) were published. Since this time ivIg have been tried for treating almost any autoimmune disease. However, reports about this treatment modality are only anecdotal. So far, ivIg are a widely used and accepted treatment only for autoimmune thrombocytopenia and Kawasaki disease. During the last years many groups tried to gain a better understanding of the mechanisms by which ivIg exert their effects in autoimmune diseases. In systemic lupus erythematosus (SLE) only case reports are available which describe encouraging positive effects of ivIg especially in patients with cytopenia and vasculitis. However in some cases a serious impairment of renal function after ivIg therapy has been reported. This was seen mainly in SLE patients who already had renal involvement before ivIg therapy was started. Therefore, extreme caution should be exercised in these patients until we know more about the pathophysiology of this side effect. We have treated 6 SLE patients with high-dose ivIg (400 mg/kg, 5 days). One patient had a remission for 6 months, another patient for 36 months; in 2 patients with preexisting reduced renal function we observed two acute renal failures and in 1 patient a decrease of the renal function 1 month after ivIg treatment. These preliminary data demonstrate the necessity of controlled clinical trials to prove the effectiveness, to define indications, to find the optimal dosage, and to study the possible mechanisms of action.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2460765542 created "2016-07-22" @default.
- W2460765542 creator A5015549021 @default.
- W2460765542 creator A5017931840 @default.
- W2460765542 creator A5059789259 @default.
- W2460765542 creator A5078920991 @default.
- W2460765542 creator A5085635227 @default.
- W2460765542 date "1993-04-01" @default.
- W2460765542 modified "2023-09-23" @default.
- W2460765542 title "[Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences]." @default.
- W2460765542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8499742" @default.
- W2460765542 hasPublicationYear "1993" @default.
- W2460765542 type Work @default.
- W2460765542 sameAs 2460765542 @default.
- W2460765542 citedByCount "1" @default.
- W2460765542 crossrefType "journal-article" @default.
- W2460765542 hasAuthorship W2460765542A5015549021 @default.
- W2460765542 hasAuthorship W2460765542A5017931840 @default.
- W2460765542 hasAuthorship W2460765542A5059789259 @default.
- W2460765542 hasAuthorship W2460765542A5078920991 @default.
- W2460765542 hasAuthorship W2460765542A5085635227 @default.
- W2460765542 hasConcept C126322002 @default.
- W2460765542 hasConcept C159641895 @default.
- W2460765542 hasConcept C159654299 @default.
- W2460765542 hasConcept C187212893 @default.
- W2460765542 hasConcept C203014093 @default.
- W2460765542 hasConcept C2776015282 @default.
- W2460765542 hasConcept C2776820930 @default.
- W2460765542 hasConcept C2776912625 @default.
- W2460765542 hasConcept C2779075594 @default.
- W2460765542 hasConcept C2779134260 @default.
- W2460765542 hasConcept C2780007613 @default.
- W2460765542 hasConcept C2780366003 @default.
- W2460765542 hasConcept C2781423770 @default.
- W2460765542 hasConcept C2909763950 @default.
- W2460765542 hasConcept C2910196583 @default.
- W2460765542 hasConcept C71924100 @default.
- W2460765542 hasConceptScore W2460765542C126322002 @default.
- W2460765542 hasConceptScore W2460765542C159641895 @default.
- W2460765542 hasConceptScore W2460765542C159654299 @default.
- W2460765542 hasConceptScore W2460765542C187212893 @default.
- W2460765542 hasConceptScore W2460765542C203014093 @default.
- W2460765542 hasConceptScore W2460765542C2776015282 @default.
- W2460765542 hasConceptScore W2460765542C2776820930 @default.
- W2460765542 hasConceptScore W2460765542C2776912625 @default.
- W2460765542 hasConceptScore W2460765542C2779075594 @default.
- W2460765542 hasConceptScore W2460765542C2779134260 @default.
- W2460765542 hasConceptScore W2460765542C2780007613 @default.
- W2460765542 hasConceptScore W2460765542C2780366003 @default.
- W2460765542 hasConceptScore W2460765542C2781423770 @default.
- W2460765542 hasConceptScore W2460765542C2909763950 @default.
- W2460765542 hasConceptScore W2460765542C2910196583 @default.
- W2460765542 hasConceptScore W2460765542C71924100 @default.
- W2460765542 hasLocation W24607655421 @default.
- W2460765542 hasOpenAccess W2460765542 @default.
- W2460765542 hasPrimaryLocation W24607655421 @default.
- W2460765542 hasRelatedWork W1632342369 @default.
- W2460765542 hasRelatedWork W1968734750 @default.
- W2460765542 hasRelatedWork W2065290543 @default.
- W2460765542 hasRelatedWork W2068107696 @default.
- W2460765542 hasRelatedWork W2083730628 @default.
- W2460765542 hasRelatedWork W2115551679 @default.
- W2460765542 hasRelatedWork W2336174611 @default.
- W2460765542 hasRelatedWork W2460765542 @default.
- W2460765542 hasRelatedWork W3029394395 @default.
- W2460765542 hasRelatedWork W3173336521 @default.
- W2460765542 hasVolume "20 Suppl 1" @default.
- W2460765542 isParatext "false" @default.
- W2460765542 isRetracted "false" @default.
- W2460765542 magId "2460765542" @default.
- W2460765542 workType "article" @default.